$ARNA News Arena shares surge as marketer doubles sales

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2013 at 11:14 PM

$ARNA News

Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Apple, Arena active; Lumber Liquidators at new high 9:06 a.m. July 25, 2012 - blogs.marketwatch.com

Arena Expands Marketing Of Obesity Drug To Help Shrink Waistlines 5:00 p.m. Today - TheStreet.com
10-Q: ARENA PHARMACEUTICALS INC 3:52 p.m. Today - Edgar Online - (EDG = 10Q, 10K)
Jim Cramer: Buy Apple, Sell AMD, and 2 More Stock Picks 12:05 p.m. Today - Wall St. Cheat Sheet
Arena Pharmaceuticals (ARNA) Worth a Look: Stock Surges 10.6% - Tale of the Tape 8:44 a.m. Today - Zacks.com
Cramer's Lightning Round - Don't Back Away From The Hottest Stock In The Universe (11/11/13) 6:03 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: 6:00 a.m. Today - TheStreet.com
Mid-Afternoon Market Update: Arena Pharma Gets a Boost on Jefferies Report as Markets Rise 2:54 p.m. Nov. 11, 2013 - benzinga.com
Trade-Ideas: Arena Pharmaceuticals (ARNA) Is Today's "Barbarian At The Gate" Stock 2:05 p.m. Nov. 11, 2013 - TheStreet.com
Tesla Owner Responds to Fire, Lululemon’s PR Battles Renew, and 3 More Hot Stocks 12:17 p.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Arena Pharmaceuticals (ARNA) Worth Watching: Stock Surges 17.4% - Analyst Blog 9:02 a.m. Nov. 11, 2013 - Zacks.com
Is Eisai Making A Down Payment On Arena? 7:17 a.m. Nov. 11, 2013 - Seeking Alpha
Arena Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 5:49 a.m. Nov. 9, 2013 - Seeking Alpha
Arena Pharma Q3 Loss Narrower than Expected - Analyst Blog 5:00 p.m. Nov. 8, 2013 - Zacks.com
U.S. Judge Orders Ex-Morgan Staney Adviser to Return Data and 2 Heavily Traded Stocks to Follow 3:59 p.m. Nov. 8, 2013 - Wall St. Cheat Sheet
VIVUS Loss In Line with Ests, Shares Fall - Analyst Blog 4:45 p.m. Nov. 7, 2013 - Zacks.com
Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement for BELVIQ 3:03 p.m. Nov. 7, 2013 - benzinga.com
Arena's Belviq Refills - Week 20 12:43 a.m. Nov. 5, 2013 - Seeking Alpha
Arena Pharmaceuticals - Belviq OTC? 3:09 a.m. Nov. 4, 2013 - Seeking Alpha
Arena's Belviq - Week 20 Sales Data 1:28 p.m. Nov. 1, 2013 - Seeking Alpha
Arena Stock Reacts To Eisai Quarterly Call 10:26 a.m. Nov. 1, 2013 - Seeking Alpha

Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena 8:00 a.m. Today - PR Newswire
GOGO, CLDX, VPHM and ARNA Added to NASDAQ Active Stock Watch List at EPR 10:14 a.m. Nov. 11, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Research on EGY, GLER, PGLO, and ARNA 12:16 a.m. Nov. 11, 2013 - ACCESSWIRE
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - PR Newswire
Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide 4:02 p.m. Nov. 7, 2013 - PR Newswire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
Must Watch Stock News: Arena Pharmaceuticals, Hewlett-Packard Company, Resorts International, Alpha Natural Resources, Chevron Corporation 1:56 p.m. Nov. 4, 2013 - PR Newswire
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 9:00 a.m. Oct. 31, 2013 - PR Newswire
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7 8:00 a.m. Oct. 30, 2013 - PR Newswire
Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros 8:00 a.m. Oct. 21, 2013 - PR Newswire
Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December 9:03 a.m. Oct. 15, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 9:26 a.m. Oct. 8, 2013 - PR Newswire
Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta 8:00 a.m. Sept. 25, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 8:00 a.m. Sept. 23, 2013 - PR Newswire
Arena Pharmaceuticals to Present Clinical Data for BELVIQ® (lorcaserin HCl) CIV at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) 8:00 a.m. Sept. 18, 2013 - PR Newswire
Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ® (lorcaserin HCl) CIV Enters Consumer Phase 8:00 a.m. Sept. 16, 2013 - PR Newswire
Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America 8:55 a.m. Sept. 13, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference 8:00 a.m. Sept. 6, 2013 - PR Newswire
Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation 8:00 a.m. Sept. 3, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

QORAI CORP's Q4 Nexus: A New AI Frontier

Breakthrough in AI: Enter Q4 Nexus It's not every day you see a tech player emerge with something genuinely fresh—QORAI CORP is shaking up the scene with its Q4 Nexus platform. This isn't just another AI model upgrade. We're talking about a rethink of the very architecture we rely on to power these systems. Founder Robby Joshi's brainchild, Q4 Nexus, jazzes up the AI...

EPG's New Malaysian Factory: A US$120M Commitment

In the hustle and bustle of manufacturing, EPG Modular Data Center has hit a landmark moment. They're not just slapping up another building—they're carving out a piece of future tech infrastructure with their fresh Malaysia FIZ Factory. Investing in Regional Strength When you pump US$120 million into a project, you're doing more than sinking cash into concrete—you're...

Teneo Expands Financial Advisory in Canada, Eyes Talent

Turning the Maple Leaf Over: Teneo's Move Alright, here's the scoop: Teneo is muscling its way north, into Canada, to flex its Financial Advisory chops. With a lineup of 60 professionals already setting the pace across Toronto, Montreal, and Calgary, this move isn’t just smoke—it’s a full-fledged expansion. They're under the hood, tinkering away to beef up...

Equinix Launches SG6: A Boost for Singapore’s AI Economy

Singapore's Strategic Role in Digital Evolution How do you blend cutting-edge tech with sustainability? Equinix has a recipe, and it’s dishing it out now in Singapore with the launch of SG6, their sixth International Business Exchange™ data center. We’re talking a near $290 million tab here—serious money for serious infrastructure, all right smack dab in one of...

CoffeeBarista.com Launches Amid High U.S. Coffee Craze

Fresh Grounds: CoffeeBarista.com Enters the Brewing Scene Alright, folks, let's cut to the chase. Digital Information Resources, the tech whiz that's been accumulating niche online properties like they're baseball cards, decided it's time to dive headfirst into the caffeinated waters with CoffeeBarista.com. Fancy name for a platform dedicated to everything bean juice,...

Kestrel Group Faces Financial Hit Despite Revenue Growth

Kestrel's Financial Rollercoaster Continues Here's the deal with Kestrel Group, folks. They just dropped their Q3 2026 financials, and it's a mixed bag. The top line's looking solid with total revenues hitting $4.8 million, riding high on a 203% jump in Program Services fee income. But dig a little deeper, and there's a $16.4 million net loss staring us in the face....

Luxury Dog Resort Opens in Dallas on November 14th

Dallas Pooches Get Star Treatment It's about time our furry pals in Dallas got a piece of high society. This ain't your run-of-the-mill doggie daycare opening a new outlet. The Wags Club, with its roots deep in Los Angeles luxury, is setting up shop near Love Field, giving Texan pups a taste of the good life. Visitors on November 14 better dress their best, and that's not...

Pen Needles Market to Hit $3.37B by 2031: Growth Ahead

Big Numbers in the Needle Game When you're staring down the numbers popping out of this pen needles market projection, it's hard to ignore—shooting from a respectable $2.16 billion in 2026 to a hefty $3.37 billion by 2031. We're talking a 9.3% CAGR that'll have investors pulling out their calculators or maybe rubbing their hands in downright glee, depending on their...

Investor Bidding on Off-Market Homes Surges 35% Higher

Investor Frenzy in Off-Market Real Estate Looking at the real estate puzzle today, one might spot an unexpected surge in enthusiasm for off-market residential properties. We've got iFinder Offers, a real estate platform that's made it its business to connect the dots between homeowners and a gaggle of over 325 hungry investors. And according to their magic spreadsheets,...

Maritime Injury Law: Neidzwski Talks Sea Changes

Legal waters are as choppy as the seas themselves, especially in the maritime injury law arena. Nicholas J. Neidzwski, a maritime injury attorney and partner at BoatLaw, LLP, recently waded into these turbulent waters at the 2026 Pacific Admiralty Seminar. This isn’t just any gathering; it’s the West Coast’s legal beacon on all things maritime, drawing in industry...